Advertisement
NBIX or QNRX or TWST
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NBIX’s FA Score shows that 0 FA rating(s) are green whileQNRX’s FA Score has 2 green FA rating(s), and TWST’s FA Score reflects 0 green FA rating(s).
- NBIX’s FA Score: 0 green, 5 red.
- QNRX’s FA Score: 2 green, 3 red.
- TWST’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NBIX’s TA Score shows that 3 TA indicator(s) are bullish while QNRX’s TA Score has 4 bullish TA indicator(s), and TWST’s TA Score reflects 5 bullish TA indicator(s).
- NBIX’s TA Score: 3 bullish, 6 bearish.
- QNRX’s TA Score: 4 bullish, 4 bearish.
- TWST’s TA Score: 5 bullish, 3 bearish.
Price Growth
NBIX (@Pharmaceuticals: Generic) experienced а -2.16% price change this week, while QNRX (@Biotechnology) price change was -0.11% , and TWST (@Medical Specialties) price fluctuated +15.42% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.51%. For the same industry, the average monthly price growth was +25.61%, and the average quarterly price growth was +11.06%.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.77%. For the same industry, the average monthly price growth was -1.57%, and the average quarterly price growth was +2024.83%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.99%. For the same industry, the average monthly price growth was +8.36%, and the average quarterly price growth was -2.66%.
Reported Earning Dates
NBIX is expected to report earnings on Aug 04, 2026.
TWST is expected to report earnings on Jul 31, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (+3.51% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Biotechnology (+0.77% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Medical Specialties (-1.99% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| NBIX | QNRX | TWST | |
| Capitalization | 15.7B | 9.17M | 5.03B |
| EBITDA | 829M | -17.36M | -106.94M |
| Gain YTD | 12.529 | -68.365 | 154.855 |
| P/E Ratio | 24.07 | 0.01 | N/A |
| Revenue | 3.1B | 0 | 409M |
| Total Cash | 1.32B | 14M | 172M |
| Total Debt | 406M | 6.21M | 95.8M |
NBIX | QNRX | TWST | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 79 | 2 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 13 Undervalued | 45 Fair valued | |
PROFIT vs RISK RATING 1..100 | 48 | 100 | 100 | |
SMR RATING 1..100 | 42 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 47 | 92 | 35 | |
P/E GROWTH RATING 1..100 | 90 | 17 | 100 | |
SEASONALITY SCORE 1..100 | 75 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
QNRX's Valuation (13) in the Biotechnology industry is in the same range as TWST (45) and is somewhat better than the same rating for NBIX (64). This means that QNRX's stock grew similarly to TWST’s and somewhat faster than NBIX’s over the last 12 months.
NBIX's Profit vs Risk Rating (48) in the Biotechnology industry is somewhat better than the same rating for QNRX (100) and is somewhat better than the same rating for TWST (100). This means that NBIX's stock grew somewhat faster than QNRX’s and somewhat faster than TWST’s over the last 12 months.
NBIX's SMR Rating (42) in the Biotechnology industry is somewhat better than the same rating for TWST (97) and is somewhat better than the same rating for QNRX (100). This means that NBIX's stock grew somewhat faster than TWST’s and somewhat faster than QNRX’s over the last 12 months.
TWST's Price Growth Rating (35) in the Biotechnology industry is in the same range as NBIX (47) and is somewhat better than the same rating for QNRX (92). This means that TWST's stock grew similarly to NBIX’s and somewhat faster than QNRX’s over the last 12 months.
QNRX's P/E Growth Rating (17) in the Biotechnology industry is significantly better than the same rating for NBIX (90) and is significantly better than the same rating for TWST (100). This means that QNRX's stock grew significantly faster than NBIX’s and significantly faster than TWST’s over the last 12 months.
| NBIX | QNRX | TWST | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 57% | 2 days ago 88% | 2 days ago 83% |
| Stochastic ODDS (%) | 2 days ago 54% | 2 days ago 90% | 2 days ago 88% |
| Momentum ODDS (%) | 2 days ago 46% | 2 days ago 90% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 58% | 2 days ago 79% | 2 days ago 87% |
| TrendWeek ODDS (%) | 2 days ago 56% | 2 days ago 90% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 55% | 2 days ago 89% | 2 days ago 81% |
| Advances ODDS (%) | 13 days ago 69% | 7 days ago 84% | 2 days ago 77% |
| Declines ODDS (%) | 2 days ago 54% | 5 days ago 90% | N/A |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 82% | 2 days ago 83% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 90% | 2 days ago 77% |
Advertisement